Study on the prescribing pattern of anti-diabetic drugs in community clinic in Uttar Pradesh state

Suresh Chandra, Mohd. Adil Khan, Anand Mohan


Objective: The diabetes mellitus is most common diseases. Which are spread all over the world. At they  are change in modified in life style disease  in this study where the prescribe drugs while using in the diagnostic and treatment of diabetes mellitus .the most commonly use drugs Sitagliptin +Metfomin in the community clinic in U.P. In the survey which are found to be the prescription pattern in Jajmau (Kanpur, U.P.) areas the most common drug which are running Sitagliptin + Metformin the survey which are randomly collect the prescription there are many variation in prescribing pattern of diabetes mellitus .the prescribing pattern is most strong tools to role of drug use in the society which are treat the DM during medication follow the proscription pattern of the drugs. There is need for appropriate safe &effective treatment and economical study to find out the pattern of drug therapy among DM.

Methods: In this study the method randomized and non randomized study design was conducted in October 2016 – November 2016 community clinic in U.P. this study found to the date which group gender in fasting blood sugar various classes of drugs analyzed them.

Results: A total of 200 patients were included in this one month’s study. All the patients had Type 2 diabetes. Metformin is the drug of choice and Sitagliptin is the most preferred combination with Metformin.

Conclusions:Insulin was not preferred as mono-therapy. Despite combination therapy, the postprandial glucose levels were not in range–suggesting either poor patient compliance or inadequate dosing/inappropriate therapy. In addition to drugs, the services of a clinical pharmacist might be helpful in these patients. Metformin is the drug of choice and Sitagliptin is the most preferred combination with Metformin.



Prescription pattern, Diabetes mellitus, Oral hypoglycemic agents, Community clinic

Full Text:



Yadav N, Thrulapati TD, Maheshwar AI, Upadhyay V, Shah P. A study on the prescribing pattern of anti-diabetic drugs in a community clinic in telangana state. Int J Pharm Pharm Sci. 2015;7(9):222-6.

Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural india: phase i reults of the indian council of medical research-india diabetes (icmr-indiab) study. Diabetologia. 2011;54:3022-7.

International diabetes federation. Idf diabetes atlas 5th.

Ramachandran A, Snehalatha C. Current scenario of diabetes in india. J Diabetes. 2009;1:18-28.

Mehta SR, Kashyap AS, Das S. Diabetes mellitus in india: the modern scourge. Mjafi. 2009;65:50-4.

The expert committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on the diagnosis and classifications of diabetes mellitus. Diabetes Care. 1997;20:1183–97.

Davis SN. Insulin, oral hypoglycemic agents, and pharmacology of the endocrine pancreas. In: brunton ll, lazo js, parker kl. Editors. Goodman and gilman`s the pharmacological basis of therapeutics. 11th ed. United States of America McGraw-Hill; 2006: 1613-45.

Powers AC. Diabetes mellitus. In: kasper dl, braunwald e, fauci as, hauser sl, lango dl, jameson jl. Editors. Harrison`s principles of internal medicine. 16th ed. New York McGraw-Hill; 2005: 2152-80.

Tedesco MA, Natale F, Di Salvo G, Caputo S, Capasso M, Calabró R. Effects of coexisting hypertension and type ii diabetes mellitus on arterial stiffness. J Hum Hypertens. 2004;18:469-73.

Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Logo of Omanmedj Oman Med J. 2012;27(4):269–73.

Bastaki S. Review diabetes mellitus and its treatment. Int J Diabetes Metabolism. 2005;13:111-34.

Norman M. Kaplan, treatment of coexisting diabetes and hypertension. Current cardiology reports riddle m. Combining sulphonyl-ureas and other oral agents. AMJ Med. 2000;108:155-225.

Mukhopadhyay P, Paul B, Das D, Sengupta N, Majumder R. Perceptions and practices of type ii diabetes: a cross-sectional study in tertiary care hospital in kolkata. Int j Diabetes Dev Countries. 2010;30:143-9.

Gul N. Knowledge, attitudes and practices of type 2 diabetic patients. J Ayub Med College. 2010;22:128-31.

Ajayi IO, Arije A, Ekore JO, J Ekore RI. Attitude; diabetic foot care, education; knowledge; type 2 diabetes mellitus. Afr Health Care Fam Med. 2010; 2.

Vermeire E, Royen PV, Coenen S, Wens J, Denekens J. The adherence of type 2 diabetes patients to their therapeutic regimens: a qualitative study from the patient’s perspective. Practical Diabetes Int. 2003;20:209-14.

Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the cross-national diabetes attitudes, wishes and needs (dawn) study. Diabetic Med J Br Diabetic Assoc. 2005;22:1379-85.

18. Hasamnis a, patil s. Prescription pattern study in type 2 diabetes mellitus in an indian referral hospital. Internet J Pharmacol. 2009;7:1.

Truter I. An investigation into ant diabetic medication prescribing in south africa. J Clin Pharm Ther 1998;23:417-22.

Adibe MO, Aguwa CN, Ukwe CV, Okonta JM, Udeogaranya PO. Outpatient utilization of anti-diabetic drugs in the south eastern nigeria. Int J Drug Dev Res. 2009;1:27-36.

Rajeshwari S, Adikhari P, Pai MR. Drug utilization study in geriatric type 2 diabetic patients. J Clin Diagn Res. 2007;1:440-3.

Khaja KA, Sequeira RP, Mathur VS. Prescribing patterns and therapeutic implications for diabetic hypertension in bahrain. Ann pharmacotherapy 2001;35:1350-9.

Hermann LS, Schersten B, Bitzen PO, Kjellstrom T, Lindgarde F, Melander A. Therapeutics comparison of metformin and sulphonyl-urea alone and in combinations: a double blind controlled study. Diabetes Care. 1994;17:1100–9.

Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65:385–411.

Riddle MC. Oral pharmacologic management of type 2 diabetes. Am Fam Physician. 1999;60:2613–20.



  • There are currently no refbacks.

Copyright (c) 2017 Pharmaceutical and Biological Evaluations

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License


© Copyright 2018 - Pharmaceutical and Biological Evaluations